PAXLOVID | Pfizer Medical Information - Gulf Countries (UAE, Oman, Bahrain, Qatar, Kuwait)

PAXLOVID

Medical Information

This medical information website is intended only for healthcare professionals in the following Gulf Countries (UAE, Oman, Bahrain, Qatar and Kuwait). This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait

Select I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait

I am a patient / caregiverNo, go back to the patient portal

Select I am a patient / caregiverNo, go back to the patient portal

March 1, 2022

The approval status of PAXLOVID varies worldwide, Pfizer does not suggest or recommend the use of our products in any other manner other than described in the Prescribing Information/ Factsheet/ EUA/ Conditional Approval. Please refer to the Prescribing Information/ Factsheet/ EUA/ Conditional Approval for important treatment considerations.

Paxlovid™ (Nirmatrelvir/ritonavir)